Stocks · Health care · Biological Products, (No Diagnostic Substances)

BIOCRYST PHARMACEUTICALS INC

BCRX Clue Score70
United States Fiscal year ends December CIK 0000882796 Results filed 4 Nov 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Alane P Barnes
22 Dec 2025
Chief Legal Officer
Sold on a plan
21,773
$7.65
$166.56K
Alane P Barnes
15 Dec 2025
Chief Legal Officer
Sold on a plan
21,210
$7.65
$162.26K
Alane P Barnes
3 Dec 2025
Chief Legal Officer
Sold on a plan
19,770
$7.65
$151.24K
Alane P Barnes
2 Dec 2025
Chief Legal Officer
Sold on a plan
50,906
$7.21
$367.22K
Machelle Sanders
13 Nov 2025
Director
Sold on a plan
9,600
$7.14
$68.54K
Nancy J Hutson
13 Dec 2024
Director
Sold on a plan
7,000
$7.54
$52.78K
Helen M. Thackray
3 Apr 2023
Chief R&D Officer
Sold on a plan
7,000
$8.29
$58.03K

What was left out

Form 4 filings counted 457
Amendments (4/A) skipped 5
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 7
Sales straight out of an exercise 86
Sales at will 21
Transactions with no price 0
Shares from compensation/vesting 8,263,448
Sales filed before the plan box existed 15
History held since 3 Nov 2006